Investor FAQ

Investor FAQ

Arcadia’s symbol on NASDAQ is RKDA.
Arcadia was founded in 2002.
Arcadia is headquartered in Davis, California. Our address is:

202 Cousteau Place, Suite 105
Davis, CA 95618
Phone: (530) 756-7077
Fax: (530) 756-7027
info@arcadiabio.com
Arcadia is a Delaware corporation.
Arcadia became a public company on May 15, 2015 and its IPO priced at $8.00 per share. The company is listed on NASDAQ as RKDA.
Arcadia does not offer a direct purchase program at this time.
Arcadia has a calendar year fiscal year. Its fiscal quarters are as follows: First Quarter: January 1 to March 31 Second Quarter: April 1 to June 30 Third Quarter: July 1 to September 30 Fourth Quarter: October 1 to December 31
Currently, Arcadia does not pay dividends, and hence does not offer a dividend reinvestment program.

Arcadia’s transfer agent is Adrian Diaz and can be reached directly at:

American Stock Transfer & Trust Company
(718) 921-8529
adiaz@amstock.com
www.amstock.com

Arcadia’s auditor is Deloitte & Touche LLP.
Arcadia’s legal counsel is Weintraub Tobin.
As of December 31, 2016, Arcadia has 57 employees.
Arcadia has two main offices and research facilities.
All news releases can be accessed on Arcadia’s web site through the News & Events link.
Documents filed with the SEC can be accessed through the Investor Relations page of the Arcadia web site.
For further information, please contact us at info@arcadiabio.com.